Abstract:Antigen delivery framework utilising polymer-based nanomaterial is broadly used in biomedicine because of their high efficacy, antigenicity and biocompatibility. In this study, hepatitis B surface antigen fabricated chitosan-polyethylene glycol nanocomposite (HBsAg-CS-PEG NC) was prepared by in situ ionic gelation method which brought about highly stable nanoformulation that was characterised by electron microscopy, atomic force microscopy (AFM) Fourier transform infrared spectroscopy (FTIR). Particles morphology by electron microscopy studies reveals spherical, electron-dense, nanostructure with 100-120 nm. AFM studies show a uniform distribution of particles with distinct roughness. Specific interaction of polymers with the vaccine or surface modification and functionalization were confirmed by FTIR analysis. Synthesised nanocomposite exhibited high antigen loading and entrapment efficiency. Release profile study carried out under in vitro condition indicates that a gradual increase in release at increasing time intervals which confirms noteworthy stability and release pattern. Enhanced immunogenicity of the nanocomposite was determined by induction of rosette formation and rate of phagocytosis using T cell rosette formation assay (TCRF assay) and mouse leukemic monocyte macrophage phagocytosis assay. Notable enhancement on rosette formation and phagocytosis percentage was recorded in nanocomposite treatment as dose-dependent manner. Biocompatibility or non-target effect was done by evaluating acute or subacute toxicity against Wistar rat model and hemocompatibility. Hemocompatibility was measured by determination of hemolysis, antioxidative enzymes, erythrocytes aggregation and serum protein profiling. No sign of toxicity and mortality was observed in all the tested parameters of nanocomposite treated animal model. Hemocompatibility studies indicate that nanocomposite treatment was not shown hemolysis, changes in antioxidative enzymes and serum protein profiling which all confirms the best biocompatibility of the synthesised nanocomposite. Phytotoxic effect of the nanocomposite studied with Vigna mungo, Vigna radiata) and Brassica nigra seeds indicate that the nanocomposite treatment was not affecting seedlings emergence or germination index. All these findings unmistakably uncover that the nanocomposite fabricated HBsAg vaccine nanoformulation utilised as a successful immunising agent which constructed from its high immunogenic property and best biocompatibility against appropriate test model framework and investigated another sight in inoculation immunology part.

Characterization of Hepatitis B Surface Antigen Loaded Polylactic Acid-Based Microneedle and Its Dermal Safety Profile

Dissolving Microneedle Arrays As a Hepatitis B Vaccine Delivery System Adjuvanted by APC-Targeted Poly (Lactic-Co-glycolic Acid) (PLGA) Nanoparticles

Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques

Liposome-loaded Dissolvable Microneedle Patches for More Efficient Intradermal Antigen Delivery of Hepatitis B Vaccine

Pharmaceutical and Immunological Evaluation of Cholera Toxin A1 Subunit as an Adjuvant of Hepatitis B Vaccine Microneedles

Separable nanocomposite hydrogel microneedles for intradermal and sustained delivery of antigens to enhance adaptive immune responses

Formulation, Characterization, and Immunogenicity of Heat-Stabilized Dissolvable Microneedles Containing a Novel VLP Vaccine

Coated Porous Microneedles for Effective Intradermal Immunization with Split Influenza Vaccine

Pharmaceutical and Immunological Evaluation of A Single-Dose Hepatitis B Vaccine Using Plga Microspheres

Mannose-Modified PLGA Nanoparticles for Sustained and Targeted Delivery in Hepatitis B Virus Immunoprophylaxis

Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination

Differential Dual‐Release Bilayer Microneedles Loaded with Aluminum Adjuvants as a Safe and Effective Vaccine Platform

Influenza Virus-Like Particles Coated Onto Microneedles Can Elicit Stimulatory Effects on Langerhans Cells in Human Skin

Mannosylated and Lipid A-Incorporating Cationic Liposomes Constituting Microneedle Arrays As an Effective Oral Mucosal Hbv Vaccine Applicable in the Controlled Temperature Chain

A Fast-Dissolving Microneedle Array Loaded with Chitosan Nanoparticles to Evoke Systemic Immune Responses in Mice.

Safety evaluation of 3-month effects of microneedle patches prepared from hyaluronic acid in mice

Intradermal Vaccination with PLGA Nanoparticles via Dissolving Microneedles and Classical Injection Needles

Poly-DL-lactide-poly(ethylene glycol) microspheres as oral and parenteral delivery systems for hepatitis B surface antigen

Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.

Hepatitis B-surface antigen (HBsAg) vaccine fabricated chitosan-polyethylene glycol nanocomposite (HBsAg-CS-PEG- NC) preparation, immunogenicity, controlled release pattern, biocompatibility or non-target toxicity

Engineering and Characterisation of BCG-loaded Polymeric Microneedles.